Risdiplam
- Part D specialty tier in 77% of formularies (2026Q3)
- EVRYSDI
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Risdiplam: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store in a refrigerator at 2°C to 8°C (36°F to 46°F) [see Dosage and Administration (2.4) ].
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- at or below 30°C (86°F)
Label statement
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature] .
- Room temperature
- at or below 30°C (86°F)
Label statement
Store the dry powder at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP controlled room temperature] .
- Room temperature
- up to 5 days at or below 40°C (104°F)
Label statement
If necessary, EVRYSDI can be kept at room temperature up to 104°F (up to 40°C) for a combined total of 5 days.
- Room temperature
- up to 5 days
Label statement
The total combined time out of refrigeration should not be more than 5 days.
- Room temperature
- up to 64 days at or below 40°C (104°F)
Label statement
Throw away (discard) any unused portion of EVRYSDI 64 days after it is mixed by the pharmacist (constitution) or if EVRYSDI has been kept at room temperature (below 104°F [40°C]) for more than a total combined time of 5 days.
- Room temperature
- at or below 25°C (77°F)
Label statement
EVRYSDI Tablets: Store at room temperature between 68°F to 77°F (20°C to 25°C).
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Keep the constituted oral solution of EVRYSDI in the original amber bottle to protect from light.
- Shaking
- Not addressed
All storage statements on the label (15)
- Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature] .
- Store the dry powder at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP controlled room temperature] .
- Keep in the original carton.
- Keep the constituted oral solution of EVRYSDI in the original amber bottle to protect from light.
- Store in a refrigerator at 2°C to 8°C (36°F to 46°F) [see Dosage and Administration (2.4) ].
- EVRYSDI for Oral Solution: Store EVRYSDI in the refrigerator between 36°F to 46°F (2°C to 8°C).
- Do not freeze.
- If necessary, EVRYSDI can be kept at room temperature up to 104°F (up to 40°C) for a combined total of 5 days.
- EVRYSDI can be removed from, and returned to, a refrigerator.
- The total combined time out of refrigeration should not be more than 5 days.
- Keep EVRYSDI in an upright position in the original amber bottle to protect from light.
- Throw away (discard) any unused portion of EVRYSDI 64 days after it is mixed by the pharmacist (constitution) or if EVRYSDI has been kept at room temperature (below 104°F [40°C]) for more than a total combined time of 5 days.
- Discard EVRYSDI if it has been kept above 104°F (40°C).
- Please see the Discard After date written on the bottle label.
- EVRYSDI Tablets: Store at room temperature between 68°F to 77°F (20°C to 25°C).
FDA label version 26, effective February 19, 2026. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
5,496 Part D plans, CMS formulary files 2026Q3. Look up tier, PA, step therapy and quantity limits by plan
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.